Jule's started off by mentioning an article that was released yesterday that was full of factually incorrect information. This was in relation to our Mt Holland contract and one at Kwinana that is not even ours.
Hopefully the Co releases a statement refuting the information and puts the record straight.
There is plenty of work, particularly in the Civil space and not enough contractors to physically undertake them all. This bodes well for NWH, a Tier 1 company that is in the box seat to win some of that work with good margins.
We missed the Tallisman contract, circa $1.1b as we were not prepared to chase contracts that would lift revenue but at the expense of margins.
The level of debt has increased due to the Cap Ex requirements, particularly for the larger contracts. $75m alone for the Karara and Kogan Creek contracts.
And no significant Cap Ex required for the second half.
Labour availability still tight.
Just a few of the snippets I noted.
- Forums
- ASX - By Stock
- Ann: NRW Half Year Results Announcement
NWH
nrw holdings limited
Add to My Watchlist
1.30%
!
$3.03

Jule's started off by mentioning an article that was released...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$3.03 |
Change
-0.040(1.30%) |
Mkt cap ! $1.385B |
Open | High | Low | Value | Volume |
$3.09 | $3.09 | $3.00 | $2.566M | 846.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | $3.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.06 | 2300 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 3.000 |
3 | 6260 | 2.980 |
2 | 1360 | 2.970 |
2 | 15330 | 2.960 |
1 | 1000 | 2.950 |
Price($) | Vol. | No. |
---|---|---|
3.060 | 2300 | 1 |
3.080 | 1000 | 1 |
3.100 | 51017 | 2 |
3.120 | 6395 | 1 |
3.160 | 3400 | 1 |
Last trade - 16.11pm 04/07/2025 (20 minute delay) ? |
Featured News
NWH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online